Global PVA Embolization Particles Market Research Report 2023

Publisher Name :
Date: 30-Jan-2023
No. of pages: 92
Inquire Before Buying

Embolization Particle or embolisation refers to the passage and lodging of an embolus within the bloodstream. It may be pathological (in which sense it is also called embolism), for example a pulmonary embolism, or therapeutic, as a hemostatic treatment for bleeding or as a treatment for some types of cancer by deliberately blocking blood vessels to starve the tumor cells.

Highlights

The global PVA Embolization Particles market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.

North American market for PVA Embolization Particles is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for PVA Embolization Particles is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global manufacturers of PVA Embolization Particles include Sirtex Medical, Merit Medical, Cook Medical, BTG Medical, Boston Scientific Corporation, Terumo Corporation, HENGRUI Medical, INterface BIOmaterials and Alicon, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for PVA Embolization Particles, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding PVA Embolization Particles.

The PVA Embolization Particles market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global PVA Embolization Particles market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the PVA Embolization Particles manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.

By Company

- Sirtex Medical

- Merit Medical

- Cook Medical

- BTG Medical

- Boston Scientific Corporation

- Terumo Corporation

- HENGRUI Medical

- INterface BIOmaterials

- Alicon

Segment by Type

- Conventional/Irregular PVA

- Compressible and Spherical PVA

Segment by Application

- Uterine Fibroid Embolization

- Prostatic Artery Embolization

- Liver Tumor Embolization

- Trauma Embolization

- Other

Consumption by Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - U.A.E

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Detailed analysis of PVA Embolization Particles manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Sales, revenue of PVA Embolization Particles in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 9: The main points and conclusions of the report.

Global PVA Embolization Particles Market Research Report 2023

Table of Contents
1 PVA Embolization Particles Market Overview
1.1 Product Overview and Scope of PVA Embolization Particles
1.2 PVA Embolization Particles Segment by Type
1.2.1 Global PVA Embolization Particles Market Value Comparison by Type (2023-2029)
1.2.2 Conventional/Irregular PVA
1.2.3 Compressible and Spherical PVA
1.3 PVA Embolization Particles Segment by Application
1.3.1 Global PVA Embolization Particles Market Value by Application: (2023-2029)
1.3.2 Uterine Fibroid Embolization
1.3.3 Prostatic Artery Embolization
1.3.4 Liver Tumor Embolization
1.3.5 Trauma Embolization
1.3.6 Other
1.4 Global PVA Embolization Particles Market Size Estimates and Forecasts
1.4.1 Global PVA Embolization Particles Revenue 2018-2029
1.4.2 Global PVA Embolization Particles Sales 2018-2029
1.4.3 Global PVA Embolization Particles Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 PVA Embolization Particles Market Competition by Manufacturers
2.1 Global PVA Embolization Particles Sales Market Share by Manufacturers (2018-2023)
2.2 Global PVA Embolization Particles Revenue Market Share by Manufacturers (2018-2023)
2.3 Global PVA Embolization Particles Average Price by Manufacturers (2018-2023)
2.4 Global PVA Embolization Particles Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of PVA Embolization Particles, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of PVA Embolization Particles, Product Type & Application
2.7 PVA Embolization Particles Market Competitive Situation and Trends
2.7.1 PVA Embolization Particles Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest PVA Embolization Particles Players Market Share by Revenue
2.7.3 Global PVA Embolization Particles Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 PVA Embolization Particles Retrospective Market Scenario by Region
3.1 Global PVA Embolization Particles Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global PVA Embolization Particles Global PVA Embolization Particles Sales by Region: 2018-2029
3.2.1 Global PVA Embolization Particles Sales by Region: 2018-2023
3.2.2 Global PVA Embolization Particles Sales by Region: 2024-2029
3.3 Global PVA Embolization Particles Global PVA Embolization Particles Revenue by Region: 2018-2029
3.3.1 Global PVA Embolization Particles Revenue by Region: 2018-2023
3.3.2 Global PVA Embolization Particles Revenue by Region: 2024-2029
3.4 North America PVA Embolization Particles Market Facts & Figures by Country
3.4.1 North America PVA Embolization Particles Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America PVA Embolization Particles Sales by Country (2018-2029)
3.4.3 North America PVA Embolization Particles Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe PVA Embolization Particles Market Facts & Figures by Country
3.5.1 Europe PVA Embolization Particles Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe PVA Embolization Particles Sales by Country (2018-2029)
3.5.3 Europe PVA Embolization Particles Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific PVA Embolization Particles Market Facts & Figures by Country
3.6.1 Asia Pacific PVA Embolization Particles Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific PVA Embolization Particles Sales by Country (2018-2029)
3.6.3 Asia Pacific PVA Embolization Particles Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America PVA Embolization Particles Market Facts & Figures by Country
3.7.1 Latin America PVA Embolization Particles Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America PVA Embolization Particles Sales by Country (2018-2029)
3.7.3 Latin America PVA Embolization Particles Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa PVA Embolization Particles Market Facts & Figures by Country
3.8.1 Middle East and Africa PVA Embolization Particles Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa PVA Embolization Particles Sales by Country (2018-2029)
3.8.3 Middle East and Africa PVA Embolization Particles Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global PVA Embolization Particles Sales by Type (2018-2029)
4.1.1 Global PVA Embolization Particles Sales by Type (2018-2023)
4.1.2 Global PVA Embolization Particles Sales by Type (2024-2029)
4.1.3 Global PVA Embolization Particles Sales Market Share by Type (2018-2029)
4.2 Global PVA Embolization Particles Revenue by Type (2018-2029)
4.2.1 Global PVA Embolization Particles Revenue by Type (2018-2023)
4.2.2 Global PVA Embolization Particles Revenue by Type (2024-2029)
4.2.3 Global PVA Embolization Particles Revenue Market Share by Type (2018-2029)
4.3 Global PVA Embolization Particles Price by Type (2018-2029)
5 Segment by Application
5.1 Global PVA Embolization Particles Sales by Application (2018-2029)
5.1.1 Global PVA Embolization Particles Sales by Application (2018-2023)
5.1.2 Global PVA Embolization Particles Sales by Application (2024-2029)
5.1.3 Global PVA Embolization Particles Sales Market Share by Application (2018-2029)
5.2 Global PVA Embolization Particles Revenue by Application (2018-2029)
5.2.1 Global PVA Embolization Particles Revenue by Application (2018-2023)
5.2.2 Global PVA Embolization Particles Revenue by Application (2024-2029)
5.2.3 Global PVA Embolization Particles Revenue Market Share by Application (2018-2029)
5.3 Global PVA Embolization Particles Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Sirtex Medical
6.1.1 Sirtex Medical Corporation Information
6.1.2 Sirtex Medical Description and Business Overview
6.1.3 Sirtex Medical PVA Embolization Particles Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Sirtex Medical PVA Embolization Particles Product Portfolio
6.1.5 Sirtex Medical Recent Developments/Updates
6.2 Merit Medical
6.2.1 Merit Medical Corporation Information
6.2.2 Merit Medical Description and Business Overview
6.2.3 Merit Medical PVA Embolization Particles Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Merit Medical PVA Embolization Particles Product Portfolio
6.2.5 Merit Medical Recent Developments/Updates
6.3 Cook Medical
6.3.1 Cook Medical Corporation Information
6.3.2 Cook Medical Description and Business Overview
6.3.3 Cook Medical PVA Embolization Particles Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Cook Medical PVA Embolization Particles Product Portfolio
6.3.5 Cook Medical Recent Developments/Updates
6.4 BTG Medical
6.4.1 BTG Medical Corporation Information
6.4.2 BTG Medical Description and Business Overview
6.4.3 BTG Medical PVA Embolization Particles Sales, Revenue and Gross Margin (2018-2023)
6.4.4 BTG Medical PVA Embolization Particles Product Portfolio
6.4.5 BTG Medical Recent Developments/Updates
6.5 Boston Scientific Corporation
6.5.1 Boston Scientific Corporation Corporation Information
6.5.2 Boston Scientific Corporation Description and Business Overview
6.5.3 Boston Scientific Corporation PVA Embolization Particles Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Boston Scientific Corporation PVA Embolization Particles Product Portfolio
6.5.5 Boston Scientific Corporation Recent Developments/Updates
6.6 Terumo Corporation
6.6.1 Terumo Corporation Corporation Information
6.6.2 Terumo Corporation Description and Business Overview
6.6.3 Terumo Corporation PVA Embolization Particles Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Terumo Corporation PVA Embolization Particles Product Portfolio
6.6.5 Terumo Corporation Recent Developments/Updates
6.7 HENGRUI Medical
6.6.1 HENGRUI Medical Corporation Information
6.6.2 HENGRUI Medical Description and Business Overview
6.6.3 HENGRUI Medical PVA Embolization Particles Sales, Revenue and Gross Margin (2018-2023)
6.4.4 HENGRUI Medical PVA Embolization Particles Product Portfolio
6.7.5 HENGRUI Medical Recent Developments/Updates
6.8 INterface BIOmaterials
6.8.1 INterface BIOmaterials Corporation Information
6.8.2 INterface BIOmaterials Description and Business Overview
6.8.3 INterface BIOmaterials PVA Embolization Particles Sales, Revenue and Gross Margin (2018-2023)
6.8.4 INterface BIOmaterials PVA Embolization Particles Product Portfolio
6.8.5 INterface BIOmaterials Recent Developments/Updates
6.9 Alicon
6.9.1 Alicon Corporation Information
6.9.2 Alicon Description and Business Overview
6.9.3 Alicon PVA Embolization Particles Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Alicon PVA Embolization Particles Product Portfolio
6.9.5 Alicon Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 PVA Embolization Particles Industry Chain Analysis
7.2 PVA Embolization Particles Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 PVA Embolization Particles Production Mode & Process
7.4 PVA Embolization Particles Sales and Marketing
7.4.1 PVA Embolization Particles Sales Channels
7.4.2 PVA Embolization Particles Distributors
7.5 PVA Embolization Particles Customers
8 PVA Embolization Particles Market Dynamics
8.1 PVA Embolization Particles Industry Trends
8.2 PVA Embolization Particles Market Drivers
8.3 PVA Embolization Particles Market Challenges
8.4 PVA Embolization Particles Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global PVA Embolization Particles Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global PVA Embolization Particles Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global PVA Embolization Particles Market Competitive Situation by Manufacturers in 2022
Table 4. Global PVA Embolization Particles Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global PVA Embolization Particles Sales Market Share by Manufacturers (2018-2023)
Table 6. Global PVA Embolization Particles Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global PVA Embolization Particles Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market PVA Embolization Particles Average Price (USD/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of PVA Embolization Particles, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of PVA Embolization Particles, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of PVA Embolization Particles, Product Type & Application
Table 12. Global Key Manufacturers of PVA Embolization Particles, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global PVA Embolization Particles by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PVA Embolization Particles as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global PVA Embolization Particles Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global PVA Embolization Particles Sales by Region (2018-2023) & (K Units)
Table 18. Global PVA Embolization Particles Sales Market Share by Region (2018-2023)
Table 19. Global PVA Embolization Particles Sales by Region (2024-2029) & (K Units)
Table 20. Global PVA Embolization Particles Sales Market Share by Region (2024-2029)
Table 21. Global PVA Embolization Particles Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global PVA Embolization Particles Revenue Market Share by Region (2018-2023)
Table 23. Global PVA Embolization Particles Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global PVA Embolization Particles Revenue Market Share by Region (2024-2029)
Table 25. North America PVA Embolization Particles Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America PVA Embolization Particles Sales by Country (2018-2023) & (K Units)
Table 27. North America PVA Embolization Particles Sales by Country (2024-2029) & (K Units)
Table 28. North America PVA Embolization Particles Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America PVA Embolization Particles Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe PVA Embolization Particles Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe PVA Embolization Particles Sales by Country (2018-2023) & (K Units)
Table 32. Europe PVA Embolization Particles Sales by Country (2024-2029) & (K Units)
Table 33. Europe PVA Embolization Particles Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe PVA Embolization Particles Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific PVA Embolization Particles Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific PVA Embolization Particles Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific PVA Embolization Particles Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific PVA Embolization Particles Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific PVA Embolization Particles Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America PVA Embolization Particles Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America PVA Embolization Particles Sales by Country (2018-2023) & (K Units)
Table 42. Latin America PVA Embolization Particles Sales by Country (2024-2029) & (K Units)
Table 43. Latin America PVA Embolization Particles Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America PVA Embolization Particles Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa PVA Embolization Particles Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa PVA Embolization Particles Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa PVA Embolization Particles Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa PVA Embolization Particles Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa PVA Embolization Particles Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global PVA Embolization Particles Sales (K Units) by Type (2018-2023)
Table 51. Global PVA Embolization Particles Sales (K Units) by Type (2024-2029)
Table 52. Global PVA Embolization Particles Sales Market Share by Type (2018-2023)
Table 53. Global PVA Embolization Particles Sales Market Share by Type (2024-2029)
Table 54. Global PVA Embolization Particles Revenue (US$ Million) by Type (2018-2023)
Table 55. Global PVA Embolization Particles Revenue (US$ Million) by Type (2024-2029)
Table 56. Global PVA Embolization Particles Revenue Market Share by Type (2018-2023)
Table 57. Global PVA Embolization Particles Revenue Market Share by Type (2024-2029)
Table 58. Global PVA Embolization Particles Price (USD/Unit) by Type (2018-2023)
Table 59. Global PVA Embolization Particles Price (USD/Unit) by Type (2024-2029)
Table 60. Global PVA Embolization Particles Sales (K Units) by Application (2018-2023)
Table 61. Global PVA Embolization Particles Sales (K Units) by Application (2024-2029)
Table 62. Global PVA Embolization Particles Sales Market Share by Application (2018-2023)
Table 63. Global PVA Embolization Particles Sales Market Share by Application (2024-2029)
Table 64. Global PVA Embolization Particles Revenue (US$ Million) by Application (2018-2023)
Table 65. Global PVA Embolization Particles Revenue (US$ Million) by Application (2024-2029)
Table 66. Global PVA Embolization Particles Revenue Market Share by Application (2018-2023)
Table 67. Global PVA Embolization Particles Revenue Market Share by Application (2024-2029)
Table 68. Global PVA Embolization Particles Price (USD/Unit) by Application (2018-2023)
Table 69. Global PVA Embolization Particles Price (USD/Unit) by Application (2024-2029)
Table 70. Sirtex Medical Corporation Information
Table 71. Sirtex Medical Description and Business Overview
Table 72. Sirtex Medical PVA Embolization Particles Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 73. Sirtex Medical PVA Embolization Particles Product
Table 74. Sirtex Medical Recent Developments/Updates
Table 75. Merit Medical Corporation Information
Table 76. Merit Medical Description and Business Overview
Table 77. Merit Medical PVA Embolization Particles Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 78. Merit Medical PVA Embolization Particles Product
Table 79. Merit Medical Recent Developments/Updates
Table 80. Cook Medical Corporation Information
Table 81. Cook Medical Description and Business Overview
Table 82. Cook Medical PVA Embolization Particles Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 83. Cook Medical PVA Embolization Particles Product
Table 84. Cook Medical Recent Developments/Updates
Table 85. BTG Medical Corporation Information
Table 86. BTG Medical Description and Business Overview
Table 87. BTG Medical PVA Embolization Particles Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 88. BTG Medical PVA Embolization Particles Product
Table 89. BTG Medical Recent Developments/Updates
Table 90. Boston Scientific Corporation Corporation Information
Table 91. Boston Scientific Corporation Description and Business Overview
Table 92. Boston Scientific Corporation PVA Embolization Particles Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 93. Boston Scientific Corporation PVA Embolization Particles Product
Table 94. Boston Scientific Corporation Recent Developments/Updates
Table 95. Terumo Corporation Corporation Information
Table 96. Terumo Corporation Description and Business Overview
Table 97. Terumo Corporation PVA Embolization Particles Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 98. Terumo Corporation PVA Embolization Particles Product
Table 99. Terumo Corporation Recent Developments/Updates
Table 100. HENGRUI Medical Corporation Information
Table 101. HENGRUI Medical Description and Business Overview
Table 102. HENGRUI Medical PVA Embolization Particles Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 103. HENGRUI Medical PVA Embolization Particles Product
Table 104. HENGRUI Medical Recent Developments/Updates
Table 105. INterface BIOmaterials Corporation Information
Table 106. INterface BIOmaterials Description and Business Overview
Table 107. INterface BIOmaterials PVA Embolization Particles Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 108. INterface BIOmaterials PVA Embolization Particles Product
Table 109. INterface BIOmaterials Recent Developments/Updates
Table 110. Alicon Corporation Information
Table 111. Alicon Description and Business Overview
Table 112. Alicon PVA Embolization Particles Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 113. Alicon PVA Embolization Particles Product
Table 114. Alicon Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. PVA Embolization Particles Distributors List
Table 118. PVA Embolization Particles Customers List
Table 119. PVA Embolization Particles Market Trends
Table 120. PVA Embolization Particles Market Drivers
Table 121. PVA Embolization Particles Market Challenges
Table 122. PVA Embolization Particles Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of PVA Embolization Particles
Figure 2. Global PVA Embolization Particles Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global PVA Embolization Particles Market Share by Type in 2022 & 2029
Figure 4. Conventional/Irregular PVA Product Picture
Figure 5. Compressible and Spherical PVA Product Picture
Figure 6. Global PVA Embolization Particles Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global PVA Embolization Particles Market Share by Application in 2022 & 2029
Figure 8. Uterine Fibroid Embolization
Figure 9. Prostatic Artery Embolization
Figure 10. Liver Tumor Embolization
Figure 11. Trauma Embolization
Figure 12. Other
Figure 13. Global PVA Embolization Particles Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global PVA Embolization Particles Market Size (2018-2029) & (US$ Million)
Figure 15. Global PVA Embolization Particles Sales (2018-2029) & (K Units)
Figure 16. Global PVA Embolization Particles Average Price (USD/Unit) & (2018-2029)
Figure 17. PVA Embolization Particles Report Years Considered
Figure 18. PVA Embolization Particles Sales Share by Manufacturers in 2022
Figure 19. Global PVA Embolization Particles Revenue Share by Manufacturers in 2022
Figure 20. The Global 5 and 10 Largest PVA Embolization Particles Players: Market Share by Revenue in 2022
Figure 21. PVA Embolization Particles Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 22. Global PVA Embolization Particles Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 23. North America PVA Embolization Particles Sales Market Share by Country (2018-2029)
Figure 24. North America PVA Embolization Particles Revenue Market Share by Country (2018-2029)
Figure 25. U.S. PVA Embolization Particles Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Canada PVA Embolization Particles Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Europe PVA Embolization Particles Sales Market Share by Country (2018-2029)
Figure 28. Europe PVA Embolization Particles Revenue Market Share by Country (2018-2029)
Figure 29. Germany PVA Embolization Particles Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. France PVA Embolization Particles Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. U.K. PVA Embolization Particles Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Italy PVA Embolization Particles Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Russia PVA Embolization Particles Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Asia Pacific PVA Embolization Particles Sales Market Share by Region (2018-2029)
Figure 35. Asia Pacific PVA Embolization Particles Revenue Market Share by Region (2018-2029)
Figure 36. China PVA Embolization Particles Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Japan PVA Embolization Particles Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. South Korea PVA Embolization Particles Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. India PVA Embolization Particles Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Australia PVA Embolization Particles Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Taiwan PVA Embolization Particles Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Indonesia PVA Embolization Particles Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Thailand PVA Embolization Particles Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Malaysia PVA Embolization Particles Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Philippines PVA Embolization Particles Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Latin America PVA Embolization Particles Sales Market Share by Country (2018-2029)
Figure 47. Latin America PVA Embolization Particles Revenue Market Share by Country (2018-2029)
Figure 48. Mexico PVA Embolization Particles Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Brazil PVA Embolization Particles Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Argentina PVA Embolization Particles Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Middle East & Africa PVA Embolization Particles Sales Market Share by Country (2018-2029)
Figure 52. Middle East & Africa PVA Embolization Particles Revenue Market Share by Country (2018-2029)
Figure 53. Turkey PVA Embolization Particles Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Saudi Arabia PVA Embolization Particles Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. U.A.E PVA Embolization Particles Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 56. Global Sales Market Share of PVA Embolization Particles by Type (2018-2029)
Figure 57. Global Revenue Market Share of PVA Embolization Particles by Type (2018-2029)
Figure 58. Global PVA Embolization Particles Price (USD/Unit) by Type (2018-2029)
Figure 59. Global Sales Market Share of PVA Embolization Particles by Application (2018-2029)
Figure 60. Global Revenue Market Share of PVA Embolization Particles by Application (2018-2029)
Figure 61. Global PVA Embolization Particles Price (USD/Unit) by Application (2018-2029)
Figure 62. PVA Embolization Particles Value Chain
Figure 63. PVA Embolization Particles Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Distributors Profiles
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs